Effects of renin‐angiotensin blockade and APOL1 on kidney function in sickle cell disease
Open Access
- 8 July 2021
- Vol. 2 (3), 483-484
- https://doi.org/10.1002/jha2.259
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- American Society of Hematology 2019 guidelines for sickle cell disease: cardiopulmonary and kidney diseaseBlood Advances, 2019
- APOL1 , α-thalassemia, and BCL11A variants as a genetic risk profile for progression of chronic kidney disease in sickle cell anemiaHaematologica, 2016
- Sickle cell disease: renal manifestations and mechanismsNature Reviews Nephrology, 2015
- APOL1 Risk Variants, Race, and Progression of Chronic Kidney DiseaseThe New England Journal of Medicine, 2013
- APOL1 Risk Variants Predict Histopathology and Progression to ESRD in HIV-Related Kidney DiseaseJournal of the American Society of Nephrology, 2012
- A New Equation to Estimate Glomerular Filtration RateAnnals of Internal Medicine, 2009